However, although IFN-γ is used as a treatment for renal cancer, idiopathic pulmonary fibrosis, and chronic granulomatous diseases, it has not been reported that autoimmune diseases occur frequently in these trials [37–39]. The gene discussed is IFNG; the disease is chronic granulomatous disease.